☆ 4.7 Article

Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History

VACCINES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

Vaccines and therapeutics for immunocompromised patients with COVID-19

Shmuel Shoham et al.

Summary: The COVID-19 pandemic has had a disproportionate impact on immunocompromised patients, who are at increased risk for impaired vaccine responses, severe disease, prolonged hospitalizations, and deaths. People with deficiencies in lymphocyte number or function, such as transplant recipients and those with hematologic malignancies, are particularly at risk. Their impaired immune responses to vaccination and infection leave them more vulnerable to high viral loads and severe complications of COVID-19, which can in turn lead to disease progression, development of immune escape variants, and transmission of infection.

ECLINICALMEDICINE (2023)

添加到收藏夹

Editorial Material Surgery

SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19

William A. Werbel et al.

Summary: Anti-spike antibody testing is important for assessing SARS-CoV-2 vaccine response in solid organ transplant recipients. It is recommended to test all recipients for anti-spike antibodies after vaccination and personalize efforts to improve protection against COVID-19 based on the results.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

添加到收藏夹

Article Surgery

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

Nassim Kamar et al.

Summary: The immunogenicity of the SARS-CoV-2 vaccine was enhanced by a third dose. A retrospective study on solid organ transplant patients found that two-thirds of them developed anti-SARS-CoV-2 antibodies after three doses, but one-third remained weak or non-protected. Antibody concentrations and protection levels decreased between 1 and 3 months after vaccination.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

添加到收藏夹

Article Medicine, General & Internal

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine A Retrospective Cohort Study

Sivan Gazit et al.

Summary: This study compares the reinfection rate between previously infected individuals who were not vaccinated and those who received a single dose of the BNT162b2 vaccine. The results show that vaccination significantly reduces the risk of reinfection and symptomatic disease.

ANNALS OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring

Antonio Cristiano et al.

Summary: In this study, two immunoassays were used to detect anti-RBD IgG levels in subjects, and it was found that vaccinated subjects had higher levels of antibodies. Both immunoassays showed a strong positive correlation with neutralizing activity. Therefore, immunoassays can be a valid alternative for large-scale monitoring of COVID-19 samples.

CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Sue Ann Costa Clemens et al.

Summary: A study was conducted to evaluate the safety and immunogenicity of a third dose of heterologous or homologous vaccines in Brazilian adults who had previously received two doses of CoronaVac. The results showed that a third dose of heterologous vaccines (recombinant adenoviral vectored vaccine or mRNA vaccine) significantly increased immune responses and could improve protection against infection.

LANCET (2022)

添加到收藏夹

Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

Victoria Hall et al.

Summary: This study investigated the duration and effectiveness of immunity among healthcare workers in the United Kingdom. It found that two doses of the BNT162b2 vaccine provided high short-term protection against SARS-CoV-2 infection, but this protection significantly decreased after six months. However, infection-acquired immunity boosted by vaccination remained high, even more than one year after infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Letter Surgery

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

Arnaud Del Bello et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Efficiency decreases

Halane Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

添加到收藏夹

Review Medicine, General & Internal

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

Ainsley Ryan Yan Bin Lee et al.

Summary: This systematic review and meta-analysis compared the efficacy of covid-19 vaccines between immunocompromised and immunocompetent individuals. The results showed that immunocompromised patients, especially organ transplant recipients, had significantly lower rates of seroconversion after covid-19 vaccination. A second dose of the vaccine consistently improved seroconversion in all patient groups, although the improvement was smaller for organ transplant recipients. Targeted interventions, including a third dose (booster) of the vaccine, should be performed for immunocompromised patients.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Letter Medicine, General & Internal

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5

Nicole P. Hachmann et al.

Summary: A small study found that omicron subvariants BA.2.12.1, BA.4, and BA.5 of SARS-CoV-2 were more likely to evade neutralizing antibodies induced by both vaccination and previous infection compared to the prior omicron subvariants BA.1 and BA.2.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections

Heba N. Altarawneh et al.

Summary: An analysis of data from Qatar showed that previous infection, vaccination, and hybrid immunity all demonstrated effectiveness in protecting against symptomatic Covid-19 caused by the BA.1 and BA.2 sublineages of the Omicron variant.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Urology & Nephrology

BNT162b2 vaccine effectiveness in chronic kidney disease patients-an observational study

Dana Bielopolski et al.

Summary: The study found that the effectiveness of two doses of the BNT162b2 vaccine was lower for CKD patients with eGFR <30 ml/min/1.73m(2) and those undergoing hemodialysis, with increased risks of severe disease and death compared to the control group. These results emphasize the importance of prioritizing CKD patients with eGFR <30 ml/min/1.73m(2) for additional vaccine doses and early COVID-19 management.

CLINICAL KIDNEY JOURNAL (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine

Maria Infantino et al.

Summary: Kidney transplant recipients (KTRs) who are low responders to COVID-19 vaccines require specific immune surveillance. This study evaluated SARS-CoV-2-specific T cell responses in KTRs with absent antibody production after a third dose of the mRNA-1273 vaccine using two different IGRA methods. The commercial IGRAs showed a good overall agreement on negative samples, but further investigations are needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Spyros Chalkias et al.

Summary: The study suggests that a bivalent COVID-19 vaccine as a booster can induce potent and broad antibody responses against multiple viral variants, providing a new tool to respond to emerging variants.

NATURE MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

Protective Effect of Previous SARS- CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants

Heba N. Altarawneh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Immunology

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

Arnaud Del Bello et al.

Summary: Kidney transplant recipients who received three doses of the mRNA vaccine did not develop adequate levels of antibodies, but a fourth dose significantly increased antibody concentration and cellular response. However, antibody concentrations remained insufficient to provide clinical protection.

VACCINES (2022)

添加到收藏夹

Letter Medicine, General & Internal

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants

Heba N. Altarawneh et al.

Summary: Prevention of Omicron can be achieved to some extent by previous SARS-CoV-2 infection, with an effectiveness of 35% for preventing reinfection with BA.4 and BA.5 subvariants and 76% for previous omicron infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Review Medicine, General & Internal

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin et al.

Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.

LANCET (2022)

添加到收藏夹

Article Virology

Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects

Elena Criscuolo et al.

Summary: This study compared two serologic tests for SARS-CoV-2, showing an increase in sensitivity over time and high specificity. However, a poor direct correlation between antibody levels and neutralizing activity was observed. These findings highlight the importance of further research on antibody kinetics and the role of neutralizing antibodies for the development of effective vaccines.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Medical Laboratory Technology

Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects

Davide Ferrari et al.

Summary: A reproducible and highly concentrated working standard (WS) specific to IgG against SARS-CoV-2 Spike-glycoprotein was developed for evaluation of post-vaccinated individuals. The WS showed good linearity and reproducibility, but exhibited different behavior compared to the WHO-IS, requiring additional factors for result harmonization.

CLINICA CHIMICA ACTA (2021)

添加到收藏夹

Article Immunology

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects

Antonio Cristiano et al.

Summary: The study aimed to detect nAbs serum levels and establish a cut-off value to identify subjects with a low risk of infection, showing a proportional increase between neutralizing activity and antibody concentration. Optimal correlations were found, making nAbs detection a good alternative to virus neutralization assays which are difficult to carry out in routine laboratories.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Article Immunology

Preventive Behaviors and Mental Health-Related Symptoms Among Immunocompromised Adults During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey

Jessica Yasmine Islam et al.

Summary: The COVID-19 pandemic has disrupted the continuity of care for U.S. adults living with chronic diseases, especially immunocompromised individuals. Immunocompromised adults are more likely to cancel doctor's appointments and experience COVID-19 related mental health symptoms.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Alasdair P S Munro et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Noam Barda et al.

Summary: A study using data from Israel's largest health-care organization showed that a third dose of the BNT162b2 mRNA vaccine is effective in preventing individuals from severe COVID-19-related outcomes, compared to receiving only two doses at least 5 months ago. The effectiveness of the third dose in preventing hospital admission was 93%, severe disease 92%, and COVID-19-related death 81%.

LANCET (2021)

添加到收藏夹

Article Virology

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

Federico Gobbi et al.

Summary: Individuals who previously contracted SARS-CoV-2 are expected to have a more rapid and sustained immune response to COVID-19 vaccines, with markedly higher titers of neutralizing antibodies compared to natural infection. A single dose of the vaccine may be sufficient to induce an effective response in previously infected individuals.

VIRUSES-BASEL (2021)

添加到收藏夹

Letter Surgery

Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients

Smaragdi Marinaki et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Immunology

Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients-Is It Related to Immunosuppression Only?

Paulina Nazaruk et al.

Summary: The study showed that transplant recipients had a higher humoral response to the BNT162b2 vaccine, with protective antibody levels of 57.1% in kidney transplant recipients and 88.9% in liver transplant recipients after the second dose. The antibody response post-vaccination was significantly associated with sex, age, and history of COVID-19.

VACCINES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant

Nassim Kamar et al.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Leonidas Stamatatos et al.

Summary: The study found that vaccination of both previously infected individuals and those who were not infected resulted in increased neutralizing antibody titers, with previously infected individuals showing a greater boost in neutralizing titers. Vaccination of naive individuals also elicited cross-neutralizing responses, but at lower titers.

SCIENCE (2021)

添加到收藏夹

Letter Surgery

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Louis Firket et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Surgery

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients

Victoria G. Hall et al.

Summary: Solid organ transplant recipients are at high risk of severe COVID-19. A study on the immunogenicity of mRNA-1273 vaccine in this population showed that a subset of patients developed neutralizing antibodies and CD4+ T cell responses, emphasizing the importance of vaccination in this patient population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Immunology

SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19

Brian J. Boyarsky et al.

TRANSPLANTATION (2021)

添加到收藏夹

Review Immunology

The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review

Yi-Chou Hou et al.

Summary: The SARS-CoV-2 pandemic poses a significant threat to global health, especially for vulnerable populations like those with chronic kidney disease. Vaccination against SARS-CoV-2 may have reduced effectiveness in individuals with CKD, requiring special attention to dosage to ensure vaccine efficacy.

VACCINES (2021)

添加到收藏夹

Article Microbiology

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects

Sarah E. Wheeler et al.

Summary: Understanding the development and duration of virus-specific antibodies after COVID-19 vaccination is important for controlling the pandemic. Postvaccination antibody testing can help in monitoring individuals after vaccination and selecting those who may require additional doses or not need vaccination.

MICROBIOLOGY SPECTRUM (2021)

添加到收藏夹

Article Virology

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays

Niko Kohmer et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.